Kromek Shares Rise After $5.9 Million Biosecurity Contract With US Government
By Elena Vardon
Kromek Group shares rose after the company said it got a $5.9 million contract from the U.S. government's Department of Homeland Security to help it detect and identify biological threats.
At 0726 GMT, shares were up 0.6 pence, or 14%, at 4.75 pence.
The supplier of detection technology said the contract--which was awarded under a four-year program--is for the agency's Countering Weapons of Mass Destruction Office covers the research and development of technologies focusing on an agent agnostic bio-detection system.
The London-listed group on Thursday said that the program starts immediately and it expects to get $874,000 during the first year base period.
Write to Elena Vardon at elena.vardon@wsj.com
(END) Dow Jones Newswires
October 26, 2023 03:48 ET (07:48 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
Why Immigration Has Boosted Job Gains and the Economy
-
What to Invest in During High Inflation
-
Never Mind Market Efficiency: Are the Markets Sensible?
-
Starbucks Stock Could Use a Pick-Me-Up After Big Selloff; Is it a Buy?
-
5 Cheap Stocks to Buy From an Attractive Part of the Market
-
Markets Brief: All Eyes On Inflation
-
5 Things We Learned From the Q1 Earnings Season
-
After Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Target Stock a Buy, a Sell, or Fairly Valued?
-
Walmart Earnings: Low Prices and Strong Digital Presence Drive Market Share Gains
-
After Earnings and a Big Selloff, Is Shopify Stock a Buy, a Sell, or Fairly Valued?
-
Cisco Earnings: Positive Guidance and Splunk Inclusion Align With Our Long-Term Thesis
-
3 Warren Buffett Stocks to Buy After Berkshire Hathaway’s Just-Released 13F Filing
-
Going Into Earnings, Is Nvidia Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is Arista Stock a Buy, a Sell, or Fairly Valued?
-
A Cheap Dividend Aristocrat to Buy Before It Bounces Back